Advanced search
Publication Cover
International Journal of Clinical and Experimental Hypnosis Volume 69, 2021 - Issue 3
Submit an article Journal homepage
3,750
Views
13
CrossRef citations to date
0
Altmetric
Articles

Hypnosis Intervention for Sleep Disturbance: Determination of Optimal Dose and Method of Delivery for Postmenopausal Women

Hypnose-Behandlung bei Schlafstörungen Bestimmung der optimalen Dosierung und Anwendungsmethode für postmenopausale Frauen

Intervention hypnotique pour les troubles du sommeil: Détermination de la dose optimale et du mode d’administration pour les femmes ménopausées

Intervención hipnótica para disturbios de sueño: Determinación de dosis óptima y método de administración para mujeres posmenopáusicas

Gary Elkinsa Mind-Body Medicine Research Laboratory, Baylor University, Waco, Texas, USACorrespondence[email protected]
View further author information
,
Julie Otteb School of Nursing, Indiana University, Indianapolis, USAView further author information
,
Janet S. Carpenterb School of Nursing, Indiana University, Indianapolis, USAORCID Iconhttps://orcid.org/0000-0003-3988-8855View further author information
ORCID Icon,
Lynae Robertsa Mind-Body Medicine Research Laboratory, Baylor University, Waco, Texas, USAView further author information
,
Lea’ S. Jacksonb School of Nursing, Indiana University, Indianapolis, USAView further author information
,
Zoltan Kekecsc Department of Psychology, Lund University, SwedenView further author information
,
Vicki Pattersona Mind-Body Medicine Research Laboratory, Baylor University, Waco, Texas, USAView further author information
&
Timothy Z. Keithd College of Education, University of Texas at Austin, USAView further author information
 show all
Pages 323-345 | Received 01 Jul 2020, Accepted 21 Oct 2020, Published online: 28 May 2021

Figures & data

Table 1. Participant Demographics

Figure 1. PRISMA Participant Flowchart

Figure 1. PRISMA Participant Flowchart

Figure 2. Program Evaluation and Treatment Satisfaction Ratings

Program Evaluation and Treatment Satisfaction. Ratings for All Intervention Groups Using a 0–10 Numerical Rating ScaleHigher scores indicate more satisfaction
Figure 2. Program Evaluation and Treatment Satisfaction Ratings

Figure 3. Percent of Participants in Each Group Achieving a Clinically Meaningful (≥ 0.5 SD) Improvement in Sleep Quality (PSQI) at Week 6 Endpoint and Week 8 Follow-Up

Figure 3. Percent of Participants in Each Group Achieving a Clinically Meaningful (≥ 0.5 SD) Improvement in Sleep Quality (PSQI) at Week 6 Endpoint and Week 8 Follow-Up

Figure 4. Percent of Participants in Each Group Achieving a Clinically Meaningful (≥ 0.5 SD) Improvement in Objective Sleep Duration (Wrist Actigraphy) at Week 6 Endpoint and Week 8 Follow-Up

Figure 4. Percent of Participants in Each Group Achieving a Clinically Meaningful (≥ 0.5 SD) Improvement in Objective Sleep Duration (Wrist Actigraphy) at Week 6 Endpoint and Week 8 Follow-Up

Figure 5. Percent of Participants in Each Group Achieving a Clinically Meaningful (≥ 0.5 SD) Improvement in Subjective Sleep Duration (Sleep Diary) at Week 6 Endpoint and Week 8 Follow-Up

Figure 5. Percent of Participants in Each Group Achieving a Clinically Meaningful (≥ 0.5 SD) Improvement in Subjective Sleep Duration (Sleep Diary) at Week 6 Endpoint and Week 8 Follow-Up

Figure 6. Percentage of Participants Achieving a Clinically Meaningful Reduction (≥ 0.5 SD) in Sleep-related Bothersomeness at Week 6 Endpoint and Week 8 Follow-Up

Figure 6. Percentage of Participants Achieving a Clinically Meaningful Reduction (≥ 0.5 SD) in Sleep-related Bothersomeness at Week 6 Endpoint and Week 8 Follow-Up

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.